๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
NCT06307652Heart Failure and Impaired Kidney Function
AstraZeneca
Phase 3
3,850
Baotou, Beijing, Changchun, Changsha, Chengdu, Chifeng, Chongqing, Guangzhou
2024-04-12
Active, closed
A Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of the Combination of BAT8008 With BAT1308 in Patients With Advanced Solid Tumors
NCT06341114Advanced Solid Tumors
Bio-Thera Solutions
Phase 1/2
112
Hangzhou
2024-04-12
Recruiting
Clinical Trial of CD19 and CD22 CAR Sequential Therapy Versus Single CD19 CAR Bridging to HSCT for r/r B-ALL Patients
NCT06343090B-cell Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, in Relapse, Refractory Acute Lymphoid Leukemia
Beijing GoBroad Hospital
Not applicable
353
Beijing
2024-04-12
Recruiting
Radical Concurrent Chemoradiotherapy With DDP/5-FU and PD-1 Antibody for Non-metastatic Rectal Squamous Cell Carcinoma
NCT06364384Rectal Squamous Cell Carcinoma
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 2
20
Guangzhou
2024-04-12
Recruiting
A Study of TAE+HAIC Combined With Camrelizumab and Apatinib in the Treatment of Advanced Hepatocellular Carcinoma
NCT06363825Advanced Hepatocellular Carcinoma
Fujian Medical University
Phase 2
57
Fuzhou
2024-04-12
Recruiting
Adebrelimab ยฑInduction Chemotherapy Followed by Concurrent Chemoradiotherapy for Unresectable Locally Advanced ESCC
NCT06510660Esophageal Squamous Cell Carcinoma, Immunotherapy, Biomarkers
Fujian Medical University Union Hospital
Phase 2
48
Fuzhou
2024-04-11
Recruiting
Safety and Efficacy of Endobronchial Valve for Bronchoscopic Lung Volume Reduction Surgery: a Prospective Pilot Study
NCT06349174Emphysema, Chronic Obstructive Pulmonary Disease
China-Japan Friendship Hospital
Not applicable
10
Beijing
2024-04-11
Recruiting
HS-20089 Combination Treatment in Subjects With Advanced Solid Tumors
NCT06336707Advanced Solid Tumors
Hansoh BioMedical R&D Company
Phase 1
1,048
Shanghai
2024-04-11
Recruiting
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC โ‰ฅ 50%) and Without Actionable Genomic Alterations
NCT06357533Non-Small Cell Lung Cancer
AstraZeneca
Phase 3
675
Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou
2024-04-11
Recruiting
Comparison of pCLE and EB in Gastric Lesion Diagnosis
NCT06389448Low Grade Intraepithelial Neoplasia, High Grade Intraepithelial Neoplasia, Early Gastric Cancer, Gastric Intraepithelial Neoplasia
Huazhong University of Science and Technology
Not applicable
366
Wuhan
2024-04-11
By invitation
Clinical Trial of Safety and Efficacy of Intracranial Laser Balloon Dilation Catheter in Patients With Symptomatic Intracranial Atherosclerotic Stenosis: A Prospective, Multi-center, Randomized Comparison
NCT06950242Prospective, Multicenter, Randomized, Controlled, and Superior Efficiency
The First People's Hospital of Changzhou
Not applicable
128
Changzhou
2024-04-11
By invitation
The Role and Mechanism of GPER-Hippo-CBS/H2S Pathway in Preeclampsia
NCT06205771Preeclampsia
Hao Feng
Not applicable
54
Jinan
2024-04-10
By invitation
FAP-targeting PET/CT for Noninvasive Monitoring of Renal Fibrosis
NCT06563765CKD, Renal Fibrosis
Peking University First Hospital
Not applicable
150
Beijing
2024-04-10
Recruiting
The Purpose of This Study is to Determine the Safety, Tolerability, and Pharmacokinetics of Brexpiprazole Long-acting Injection Following a Single Administration in Healthy Subjects/Patients With Schizophrenia.
NCT06674694Schizophrenia Disorders
Sichuan Kelun Pharmaceutical Co.,Ltd.
Phase 1
56
Beijing
2024-04-10
Active, closed
Phase Ib Study of Rocbrutinib in Combination With R-CHOP in Patients With Newly Diagnosed B-cell Non-Hodgkin Lymphoma
NCT06251180B-cell Non-Hodgkin Lymphoma
Guangzhou Lupeng Pharmaceutical Company LTD.
Phase 1
112
Guangzhou
2024-04-10
Recruiting
Lymph Node Pathologic Grading Strategy
NCT06745830Lung Adenocarcinoma
Fudan University
Observational
2,998
Shanghai
2024-04-10
Recruiting
Exploratory Study on the Treatment of Gout With Potassium Citrate Sustained-release Tablets
NCT06966635Hyperuricemia or Gout, Nephrolithiasis
Huashan Hospital
Phase 4
312
Shanghai
2024-04-10
Recruiting
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
NCT06330064Recurrent or Metastatic Solid Tumors
Daiichi Sankyo
Phase 1/2
680
2024-04-10
Active, closed
A Study of Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Renal Cell Carcinoma (V940-004).
NCT06307431Renal Cell Carcinoma
Merck Sharp & Dohme LLC
Phase 2
272
2024-04-10
Recruiting
AK104 in Combination With AK112 Plus Chemotherapy(SOX/XELOX) as First-line Treatment for Advanced G/GEJ Cancer
NCT06196697Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
Harbin Medical University
Phase 2
50
Harbin
2024-04-10
Recruiting
An Exploratory Clinical Study of SCAR02 Targeting BCMA and CD19 for the Treatment of Refractory Autoimmune Diseases
NCT06503224Autoimmune Diseases
The First Affiliated Hospital of University of Science and Technology of China
Not applicable
18
Changsha
2024-04-09
Recruiting
RANK-ligand Inhibition to Combat Sarcopenia With Underlying Osteoporosis
NCT06643780Sarcopenia in Elderly
Prince of Wales Hospital, Shatin, Hong Kong
Phase 4
120
Hong Kong
2024-04-09
Active, closed
A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guรฉrin (BCG)
NCT06211764Non-Muscle Invasive Bladder Neoplasms
Janssen Research & Development, LLC
Phase 3
272
Beijing, Cheng Du Shi, Chongqing, Guangzhou, Shenyang, Tianjin, Wenzhou, Wuhan
2024-04-09
Recruiting
Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3)
NCT06402708Thymic Carcinoma
Fudan University
Phase 3
172
Shanghai
2024-04-09
Active, closed
A Study of DM919 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors
NCT06328673Advanced Solid Tumor
D2M Biotherapeutics Inc.
Phase 1
160
Beijing
2024-04-09
Recruiting
Osimertinib Plus Dalpiciclib in Patients With EGFR-mutant, CDK4/6 Pathway Aberrant, Advanced Non-small Cell Lung Cancer Following Acquired Resistance to Third-generation EGFR TKI: a Phase II Trial
NCT06363734Non-small Cell Lung Cancer, EGFR Activating Mutation, Cell Cycle Deregulation, EGFR-TKI Resistant Mutation
Tianjin Medical University Cancer Institute and Hospital
Phase 2
32
Tianjin
2024-04-09
Recruiting
Doxycycline and Progestin Therapy for Chronic Endometritis(CE) in Patients With Recurrent Reproductive Failure(RRF)
NCT07488949Chronic Endometritis
Fang Wang
Not applicable
1,000
Lanzhou
2024-04-09
Recruiting
Risk Stratification, Early Prevention and Treatment Strategies for Arrhythmogenic Cardiomyopathy
NCT06352307Arrhythmogenic Cardiomyopathy
First Affiliated Hospital Xi'an Jiaotong University
Observational
1,500
Xi'an
2024-04-09
Recruiting
Efficacy and Safety of Fecal Microbiota Transplantation (FMT) in Reducing Recurrence of Colorectal Adenoma (CRA)
NCT06205862Fecal Microbiota Transplantation, Colorectal Adenoma, Gastrointestinal Microbiome
Shenzhen Hospital of Southern Medical University
Phase 2
466
Guangzhou, Shenzhen, Shunde
2024-04-09
Not yet open
Sub-lobectomy for IDH Wild-type and TERT Promoter Mutant Glioblastoma
NCT06368934Glioma, Glioblastoma
Huashan Hospital
Not applicable
326
Shanghai
2024-04-08
Recruiting
Circulating Tumor DNA Methylation Guiding Postoperative Adjuvant Chemotherapy in Stage III Colorectal Cancer
NCT06167967Colorectal Cancer
Sir Run Run Shaw Hospital
Not applicable
990
Hanzhou
2024-04-08
Recruiting
Edaravone Dexborneol Sublingual Tablet for the PSCI in Acute Ischemic Stroke Patients
NCT06315231Post-stroke Cognitive Impairment
Simcere Pharmaceutical Co., Ltd
Phase 2
226
Fuyang, Hefei, Huangshan City, Guangzhou, Wuzhou, Shijiazhuang, Zhumadian, Nanchang
2024-04-08
Recruiting
Irinotecan Liposome Combined With Oxaliplatin and Tegafur as Adjuvant Therapy for Pancreatic Cancer
NCT06361316Pancreatic Cancer, Adjuvant Therapy
Kuirong Jiang
Not applicable
53
Nanjing
2024-04-08
Recruiting
A Phase I Study on ReT01 ACT for the Treatment of Advanced Solid Tumors
NCT06257680Advanced Solid Tumor
Beijing Xunsheng Biomedical Research Co., Ltd.
Phase 1
15
Beijing
2024-04-08
Recruiting
T Cell Receptor Gene-Engineered T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor
NCT06484790Tumor, Solid
Ting Deng
Phase 1
9
Tianjin
2024-04-08
Recruiting
Modified Intermittent Eating on Weight Loss (INTEREST-3 Trial)
NCT06302803Obesity
Nanfang Hospital, Southern Medical University
Not applicable
225
Guangzhou
2024-04-07
By invitation
The Diagnostic Value of Shear Wave Elastography and Viscosity Imaging Techniques in Diabetic Peripheral Neuropathy
NCT06773793Diabetic Peripheral Neuropathy (DPN)
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
300
Nanjing
2024-04-07
Recruiting
A Study of Lisaftoclax (APG-2575) Combined With Acalabrutinib Versus Immunochemotherapy for Newly Diagnosed CLL/SLL.
NCT06319456CLL/SLL
Ascentage Pharma Group Inc.
Phase 3
344
Bengbu, Guangzhou, Zhanjiang, Zhengzhou, Wuhan, Changsha, Shanghai, Tianjin
2024-04-07
Recruiting
Efficacy of Songling Xuemaikang Capsules on Grade 1 Hypertension: a Randomized Controlled Trial
NCT06093932Hypertension,Essential
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Phase 4
100
Beijing, Suzhou, Jinan, Jining, Taiyuan
2024-04-07
Recruiting
Exploratory Study on HER2 Detection Method and Positive Threshold for High-grade Serous Adenocarcinoma of the Ovary
NCT06883487Exploring HER2 Positive Diagnostic Criteria in High-grade Serous Ovarian Cancer, Observing the Effectiveness of Targeted HER2 ADC Drugs
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Observational
144
Guangzhou
2024-04-07
Recruiting
A First-ever Research Collaboration to Characterize MRI Measured Neural Flexibility Development in Chinese Toddlers
NCT04916652Growth & Development, Brain
Sociรฉtรฉ des Produits Nestlรฉ (SPN)
Observational
60
Shanghai
2024-04-06
Recruiting
Auditory Restoration and Outcomes After Gene Therapy and Cochlear Implantation: a PRospective Cohort Analysis (AURORA)
NCT06237790Hearing Loss, Genetic Disease, Speech Perception
Eye & ENT Hospital of Fudan University
Observational
180
Beijing, Zhengzhou, Changsha, Nanchang, Shanghai, Chengdu
2024-04-06
Not yet open
Efficacy and Safety of Intraparenchymal Portal Vein Covered Stents in Treating Portal Hypertension and Its Complications
NCT06320912Portal Hypertension
Shanghai Shenqi Medical Technology Co., Ltd
Not applicable
258
Guangzhou
2024-04-05
Recruiting
Combination of SBRT and Immunotherapy in Small Hepatocellular Carcinoma (HSBRT2402)
NCT06313190Hepatocellular Carcinoma
Sun Yat-sen University
Phase 2
140
Guangzhou
2024-04-05
Recruiting
ฮ’-Thalassemia Treatment with KL003 Cell Injection
NCT06280378Transfusion-dependent Beta-Thalassemia
Kanglin Biotechnology (Hangzhou) Co., Ltd.
Phase 1/2
41
Shanghai, Tianjin
2024-04-05
Recruiting
TLSA Versus TBSA Surgical Approach for Hiatal Hernia With Gastroesophageal Reflux Disease
NCT07252115Hernia, Hiatal, GERD (Gastroesophageal Reflux Disease)
Beijing Friendship Hospital
Not applicable
143
Beijing
2024-04-04
Active, closed
An International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study With Open-Label Extension Evaluating the Efficacy and Safety of Diacerein 1% Ointment for the Treatment of Generalized Epidermolysis Bullosa Simplex (EBS)
NCT06073132Generalized Epidermolysis Bullosa Simplex
TWi Biotechnology, Inc.
Phase 2/3
80
Guangzhou
2024-04-04
Recruiting
Checkpoint Inhibitor Combinations Therapy as First Line for Inoperable Lung Cancer Via IT
NCT06483347Lung Cancer, Inoperable Disease
Second Affiliated Hospital of Guangzhou Medical University
Phase 2
90
Guangzhou
2024-04-04
Recruiting
Serplulimab Combined With CCRT for LS-SCLC.
NCT06295926Small Cell Lung Cancer
Peking Union Medical College Hospital
Phase 2
96
Beijing
2024-04-04
Recruiting
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
NCT06312137Non Small Cell Lung Cancer
Merck Sharp & Dohme LLC
Phase 3
780
Beijing, Fuzhou, Guangzhou, Zhengzhou, Wuhan, Changsha, Nanjing, Suzhou
2024-04-03
Recruiting
Comparing the Efficacy of VHAG and Traditional Chemotherapy Regimens in Newly Diagnosed ETP-ALL
NCT06361329ETP-ALL
First Affiliated Hospital of Zhejiang University
Phase 3
81
Hangzhou
2024-04-03
Recruiting
Toripalimab Combined With Cryoablation for First-line Oligo-progression in Driver-negative Advanced NSCLC
NCT06127303Non-small Cell Lung Cancer
Shanghai Chest Hospital
Phase 2
54
Shanghai
2024-04-02
By invitation
the Prevention of Bone Marrow Suppression Caused by Chemotherapy in Advanced NSCLC With Trilaciclib
NCT06370416Non-small Cell Lung Cancer
Henan Cancer Hospital
Phase 2
41
Zhengzhou
2024-04-02
Recruiting
Chemotherapy Omission in ER+/HER2- Breast Cancer With 1-3 Positive Lymph Nodes Receiving Extended Adjuvant Abemaciclib
NCT06341621Breast Cancer
Fudan University
Phase 3
1,900
Shanghai
2024-04-02
Active, closed
Long-term, Open-label, Safety Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorder (NMOSD)
NCT06180278Neuromyelitis Optica Spectrum Disorder
Amgen
Phase 4
32
Hong Kong
2024-04-02
Recruiting
Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients With Recurrent or Metastatic Cervical Cancer
NCT06241781Adult
Grit Biotechnology
Phase 2
83
Beijing, Fuzhou, Shenzhen, Guilin, Haโ€™erbin, Luoyang, Zhengzhou, Wuhan
2024-04-02
Recruiting
Fecal Microbiota Transplantation (FMT) in Patients With Advanced Gastric Cancer
NCT06346093Advanced Gastric Cancer
Changhai Hospital
Not applicable
124
Shanghai
2024-04-02
Recruiting
LAA Clipping Versus NOACs to Prevent Stroke in Non-paroxysmal Atrial Fibrillation.
NCT06021808Non-paroxysmal Atrial Fibrillation
China National Center for Cardiovascular Diseases
Not applicable
290
Beijing
2024-04-02
By invitation
Application of Bacterial DNA Quantitative Detection in Diagnosis of SBP in Cirrhosis: A Multi Center Diagnostic Experiment
NCT06995846Cirrhosis, Ascites, Bacterial Infections
Beijing YouAn Hospital
Observational
700
Beijing
2024-04-02
Recruiting
Trilaciclib for the Prevention of Chemoradiotherapy-Induced Myelosuppression in Esophageal Squamous Cell Carcinoma
NCT06698692ESCC
The First Affiliated Hospital with Nanjing Medical University
Observational
200
Nanjing
2024-04-02
Recruiting
Optimised CD33 (FL-33) CAR T Therapy for Refractory/Relapsed Acute Myeloid Leukaemia
NCT06326021Refractory/Relapsed Acute Myeloid Leukaemia
Beijing GoBroad Hospital
Phase 1
27
Shanghai, Chengdu, Beijing
2024-04-02
Recruiting
Comparison of Compressed Continuous Suture and Conventional Suture in Pterygium Surgery
NCT07244276Primary Pterygium
Tianjin Eye Hospital
Not applicable
40
Tianjin
2024-04-02
Recruiting
Efficacy and Safety of Low-dose Chemotherapy Plus Immuno-targeted Drugs in Newly Diagnosed Adult Ph- B-ALL
NCT06387121Precursor Cell Lymphoblastic Leukemia-Lymphoma
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
53
Tianjin
2024-04-02
Recruiting
Fruquintinib in Combination With Tislelizumab Followed by Radiotherapy in Esophageal Squamous Cell Carcinoma
NCT06646588Esophageal Neoplasms
Hebei Medical University Fourth Hospital
Phase 2
67
Shijiazhuang
2024-04-01
Recruiting
CLL-1 CAR-NK Cells for Relapsed/Refractory AML
NCT06307054Relapsed Adult AML, Refractory AML
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 1
24
Shanghai
2024-04-01
Recruiting
Study of 5% VVN001 Ophthalmic Solution in Dry Eye Disease
NCT06360133Dry Eye
VivaVision Biotech, Inc
Phase 3
700
Shanghai
2024-04-01
Recruiting
The Outcomes of Ultrasound-guided Thermal Ablation for Benign Thyroid Nodules
NCT06340945Thyroid Nodules
Chinese PLA General Hospital
Not applicable
1,500
Beijing
2024-04-01
Active, closed
Application of 68Ga-NODAGA-SNA006 Positron Emission Tomography/Computed Tomography (PET/CT) in Tumors
NCT07059832Cancer
First Hospital of China Medical University
Phase 1/2
30
Shenyang
2024-04-01
Not yet open
OCT or Angiography Guided De-escalation of DAPT
NCT06339021Optical Coherence Tomography, Dual Antiplatelet Therapy, Antiplatelet De-escalation, Neointimal Coverage
Shenyang Northern Hospital
Phase EARLY_PHASE1
80
Shenyang
2024-04-01
Recruiting
Century Clot-Guided Prophylactic Rivaroxaban for Post STEMI Complicating Left Ventricular Thrombus
NCT06013020STEMI - ST Elevation Myocardial Infarction
Zunyi Medical College
Phase 4
374
Zunyi
2024-04-01
Recruiting
The Safety, Tolerability, and Efficacy of KD01 in Gynecologic Malignancies
NCT06552598Cervical Cancer, Gynecologic Malignancies, Endometrial Cancer
Tongji Hospital
Phase 1
97
Wuhan
2024-04-01
Recruiting
Fundus Optical coheRence Tomography Angiography Evaluation for Small-vessel Health in Cerebral Small Vessel Disease
NCT06431711Cerebral Small Vessel Diseases, Retinal Ischemia, Choroid; Injury
Zhejiang Provincial People's Hospital
Observational
2,400
Hangzhou
2024-04-01
Recruiting
mFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic Cancer Refractory to Chemotherapy
NCT06249321Pancreatic Cancer, Radiotherapy
Fudan University
Phase 2
30
Shanghai
2024-04-01
Recruiting
Neoantigen Vaccine Plus Anti-PD1 and Chemotherapy as an Adjuvant Therapy for Pancreatic Cancer
NCT06344156Pancreatic Cancer, Adjuvant Therapy
Sichuan University
Phase 1
43
Chengdu
2024-04-01
Recruiting
Research on the Potential Mechanisms Underlying the Efficacy Differences in Specific Neoadjuvant Treatment Regimens for Different Subtypes of Breast Cancer
NCT07012720Breast Cancer
Xijing Hospital
Not applicable
71
Xi'an
2024-04-01
Recruiting
Clinical Characteristics of Sleep Disorders in Patients With Ulcerative Colitis
NCT06359808Colitis, Ulcerative, Sleep Quality, Gastrointestinal Microbiome, Autonomic Nervous System Imbalance
Xijing Hospital
Observational
152
Xi'an
2024-04-01
By invitation
The Factors Affecting IPP in Peritoneal Dialysis Patients with Polycystic Kidney Disease
NCT06841224Peritoneal Dialysis, Polycystic Kidney Diseases
Peking University First Hospital
Observational
30
Beijing
2024-04-01
Recruiting
Effect of Electroacupuncture Combined With Paclitaxel Clinical Efficacy of Patients With Recurrence of High-grade Glioma
NCT06330337Glioma
The Third Affiliated hospital of Zhejiang Chinese Medical University
Phase 3
58
Zhejiang
2024-04-01
Recruiting
Wearable Devices Faciliate the Management of AMI Patients
NCT06995495Acute Myocardial Infarction
RenJi Hospital
Observational
400
Shanghai
2024-04-01
Not yet open
Aerobic Dance During Chemotherapy in Breast Cancer Patients With Cognitive Impairment
NCT06234150Breast Neoplasms, Exercise Therapy, Chemotherapy-Related Cognitive Impairment, Cognitive Dysfunction
The First Affiliated Hospital with Nanjing Medical University
Not applicable
90
Nanjing
2024-04-01
Recruiting
Bowel Sound in Predicting the Severity of Acute Pancreatitis: Protocol of a Prospective, Multi-center Study
NCT06867120Acute Pancreatitis (AP), Severe Acute Pancreatitis
Peking Union Medical College Hospital
Observational
352
Beijing
2024-04-01
Recruiting
Triple vs. Dual Adjuvant Therapy Following Liver Resection for HCC.
NCT06311942HCC
Chen Xiaoping
Phase 4
300
Wuhan
2024-04-01
Recruiting
Concurrent Chemoradiotherapy Combined With Sintilimab as Neoadjuvant Therapy for GC Patients With PALM
NCT06341595Gastric Cancer, Gastric Cancer Metastatic to Regional Lymph Nodes
The First Affiliated Hospital with Nanjing Medical University
Phase 2
40
Nanjing
2024-04-01
Recruiting
Study on the Safety and Efficacy of MR-Linac Technique in Patients With Unresectable Locally Advanced Colon Cancer
NCT06244537Safety and Efficacy
Sichuan Cancer Hospital and Research Institute
Not applicable
20
Chengdu
2024-04-01
Recruiting
Evaluate the Efficacy and Safety of Atorvastatin Combined With Temozolomide in the Treatment of Glioblastoma
NCT06327451Glioblastoma, IDH-wildtype
Tianjin Medical University General Hospital
Phase 2
50
Tianjin
2024-04-01
Not yet open
Value of Dynamic Monitoring of Early Recurrence of Hepatocellular Carcinoma After Radical Resection Based on CTCS
NCT06317896Hepatocellular Carcinoma, Circulating Tumor Cell, Recurrence, Surgery
Zhujiang Hospital
Observational
82
Foshan, Guangzhou
2024-04-01
Recruiting
Cohort-Based Study of Diagnostic Biomarkers for Neurosyphilis
NCT06680011Neurosyphilis, Biomarkers, Proteomics
Shanghai Mental Health Center
Observational
360
Shanghai
2024-04-01
Recruiting
Early Pancreatic Stent Placement for Preventing PEP
NCT06250803Cholangiopancreatography, Endoscopic Rretrograde, Post-ERCP Pancreatitis
The First Affiliated Hospital of Anhui Medical University
Not applicable
768
Hefei
2024-04-01
Active, closed
Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B Without Inhibitors
NCT06569108Hemophilia A Without Inhibitor, Hemophilia B Without Inhibitor
Suzhou Alphamab Co., Ltd.
Phase 3
125
Tianjin
2024-04-01
Not yet open
Transfusion in Cardiac Valve Surgery
NCT06332547Cardiac Surgery With Cardiopulmonary Bypass, Valve Heart Disease
Guangdong Provincial People's Hospital
Not applicable
1,600
Guangzhou
2024-04-01
Recruiting
the Clinical Effect of TCM Sniffing Therapy Combined With Electroacupuncture in PSCI
NCT06313866Stroke
Hangzhou Medical College
Not applicable
220
Hangzhou
2024-04-01
Recruiting
Development of Prosocial Behaviors and Related Brain Network in Infants of High and Low Risk of ASD
NCT06329245Autism or Autistic Traits, Healthy
Children's Hospital of Fudan University
Observational
100
Shanghai
2024-04-01
Recruiting
The Hi-tACS on Cognitive Function in Patients With Schizophrenia
NCT06470516Schizophrenia
Sir Run Run Shaw Hospital
Not applicable
100
Hanzhou, Quzhou
2024-04-01
Active, closed
The Ameliorative Effect of C-Kit (+) Hepatic Endothelial Cells With Mertk Deficiency on Nonalcoholic Steatohepatitis
NCT06913699Non-alcoholic Fatty Liver Disease (NAFLD)
Shanghai East Hospital
Observational
6
Shanghai
2024-04-01
Recruiting
pBFS Guided rTMS Over Cognitive Control Network for ASD
NCT06255535Autism Spectrum Disorder
Changping Laboratory
Not applicable
215
Fuzhou, Baoding, Xi'an, Jining, Linyi
2024-04-01
Recruiting
Interventional Software for Multi-immunotherapy of Solid Tumors
NCT06478108Lung Cancer, Liver Cancer, Solid Tumor, Adult
Second Affiliated Hospital of Guangzhou Medical University
Phase 2/3
60
Guangzhou
2024-04-01
Recruiting
VA vs DA for Newly Diagnosed Hig-risk AML
NCT05939180Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University
Phase 2/3
116
Suzhou
2024-04-01
Recruiting
Short-course Radiotherapy Combined With CAPOX and PD-1 Antibody Versus Long-course Chemoradiotherapy Combined With CAPOX for Early Low-lying Rectal Cancer
NCT06462053Early Low Rectal Cancer
Fudan University
Phase 2
134
Shanghai
2024-04-01
Recruiting
Study on MRD Prediction of Efficacy of Toripalimab in the Treatment of High-risk Recurrent Renal Carcinoma
NCT07657325Renal Cell Carcinoma (RCC)
Tianjin Medical University Second Hospital
Observational
110
Tianjin
2024-04-01
Recruiting
Genomic Biomarker-guided Neoadjuvant Therapy for Prostate Cancer (SEGNO)
NCT06387056Locally Advanced Prostate Cancer, Oligometastatic Prostate Cancer
The First Affiliated Hospital of Xiamen University
Phase 2
40
Xiamen
2024-04-01
Rows per page Showing 13101–13200 of 19052
Previous 130 131 132 133 134 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china?page=132

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.